Jun. 24 at 6:30 PM
$RGNX $RGNX Connecting the dots. The script is playing out perfectly:
1️⃣ The Hype: 2 PRs in 48h. Today’s PR only adds that all patients are dosed; everything else is recycled from May's RBC call to pump the stock & volume above
$10.
2️⃣ Smoking Gun: 10 new MSL jobs posted. High-cost hiring means the
$100M AbbVie (
$ABBV) cash milestone is a done deal. Expect that PR by Friday.
3️⃣ No Gambling: Management won't wait for Q4 or gamble on
$RGX-121 timelines. They need a cash fortress now to launch the Duchenne (
$RGX-202) program globally.
4️⃣ The Big Picture: Expect a clean, moderate ~
$150M growth raise right after the AbbVie PR. Easily absorbed by institutions.
Once this financing overhang clears, the bear thesis is dead. Bullish mid-term. 📈
